| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.77B | 0.00 | 20.41B | 0.00 | 0.00 | 0.00 |
| Gross Profit | 15.01B | -4.65B | 15.78B | -3.56B | -3.55B | -3.16B |
| EBITDA | 5.87B | 8.58B | 4.35B | 9.21B | 11.18B | 12.40B |
| Net Income | 2.05B | 1.90B | 1.52B | 2.82B | 4.24B | 5.18B |
Balance Sheet | ||||||
| Total Assets | 214.67B | 205.68B | 191.35B | 148.62B | 150.71B | 164.76B |
| Cash, Cash Equivalents and Short-Term Investments | 24.08B | 20.15B | 20.42B | 17.17B | 22.23B | 37.40B |
| Total Debt | 117.44B | 179.92B | 151.12B | 102.16B | 95.32B | 134.16B |
| Total Liabilities | 172.55B | 163.52B | 149.40B | 115.88B | 118.83B | 134.67B |
| Stockholders Equity | 41.99B | 42.00B | 42.01B | 32.77B | 31.89B | 30.09B |
Cash Flow | ||||||
| Free Cash Flow | 346.00M | 0.00 | -4.09B | 875.00M | 3.19B | 4.22B |
| Operating Cash Flow | -9.49B | -5.37B | -3.42B | 1.50B | 3.72B | 4.75B |
| Investing Cash Flow | -5.11B | -5.16B | 544.00M | -712.00M | -698.00M | -777.00M |
| Financing Cash Flow | 22.54B | 10.26B | 6.13B | -5.85B | -18.19B | 18.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥78.61B | 21.69 | ― | 2.02% | 13.52% | 7.75% | |
81 Outperform | ¥25.37B | 17.71 | ― | 2.50% | 16.70% | 22.23% | |
73 Outperform | ¥9.56B | 5.72 | ― | 3.94% | 7.06% | 34.95% | |
72 Outperform | ¥3.15B | 3.97 | ― | 2.04% | 12.86% | -63.06% | |
69 Neutral | ¥439.31B | 16.35 | 14.42% | 4.80% | 10.39% | 12.77% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
51 Neutral | ¥38.05B | 11.37 | ― | 4.51% | 4.86% | -10.59% |